ClinicalTrials.gg
Not yet recruitingNCT07949825Updated Nov 19, 2026

Effect of Carotid Corrected Flow Time Guided Fluid Management on Post-Induction Hypotension in Elderly Patients

An observational study in Post-induction Hypotension (PIH), sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Not yet recruiting at 1 site in China. Open to participants aged 65 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine · Observational

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
102
Ages
65 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 59 studies in Hypotension with a site in China — 26 open to participants now, 29 under way, none of them phase 3. Hypotension · China.

Planned enrollment
15th of 19
102 · median 200
Started
2026
with 10 others
Observational
19 of 59
9 open now
Primary completion
2027-01
later than 18 of 28 live
Registered
59th of 59
by date

Among the 59 studies in Hypotension with a site in China, this one is the 15th largest by planned enrollment of the 19 observational ones that give a count, is one of 11 that started in 2026, is one of 19 observational ones, reaches primary completion later than 18 of the 28 other live ones, and was the 59th registered.

Hypotension

893 studies on the registry are indexed under Hypotension; 197 are open to participants now.

Browse Hypotension studies →

Open to participants now

26 of the 59 studies in Hypotension with a site in China are open now. Recruiting first, the newest first:

20 more — sign in →

All 26 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 112 Hypotension studies recruiting now, 51 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 15 take healthy volunteers.

This study: 65 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 59 studies in Hypotension with a site in China, or all of them as a file.
02

Study summary

This study aimed to investigate the effect of carotid corrected flow time (FTc)-guided fluid management on post-induction hypotension in elderly patients undergoing general anesthesia.

03

Conditions studied

  • Post-induction Hypotension (PIH)

Browse trials for

04

Who can participate

Ages eligible
65 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Elderly patients aged ≥65 years scheduled for elective non-cardiac surgery under general anesthesia, ASA physical status I-III. Patients with emergency surgery, preoperative unstable hemodynamics, severe cardiovascular disease, pre-existing hypotension, or inability to obtain written informed consent will be excluded. Consecutive eligible patients will be enrolled in this single-center prospective observational study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • > 1. Obtain the form; > 2. Patients undergoing elective surgery under general anesthesia; > 3. (ASA) physical status classification I-III; > 4. Aged 65-80 years; > 5. Patients voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion Criteria:

  • 1. Patients with sudden and life-threatening changes in preoperative vital signs; 2. History of neck surgery or trauma; 3. History of severe peripheral arterial disease or atherosclerosis; 4. > 30 kg/m² or \< 15 kg/m²; 5. History of cardiomyopathy or valvular heart disease; 6. (LVEF) \< 50%; 7. Patients with an implanted pacemaker or implantable cardioverter-defibrillator (ICD); 8. Right ventricular dysfunction; 9. (COPD); 10. Patients with secondary hypertension; 11. Patients with unclear ultrasound measurements, sustained blood pressure > 180/110 mmHg, temporary withdrawal, or unexpected difficult airway; 12. Patient refusal.
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
102 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Observation cohort

    All enrolled elderly patients undergoing non-cardiac surgery under general ansethesia.No investigational intervention will be performed.Anesthesia management follows routine clinical practice

06

What researchers measure

Primary outcomes

  1. Incidence of post-induction hypotension

    The incidence of post-induction hypotension, defined as SBP reduction \>30% from baseline, or MAP reduction \>20% from baseline, or SBP\<90 mmHg together with MAP\<60 mmHg within 5 minutes after anesthesia induction. Baseline blood pressure refers to stable blood pressure measured before induction.

    Time frame: Within 5 minutes after anesthesia induction

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — ndividual participant data will not be shared publicly due to patient privacy protection and institutional data management regulations. Aggregated study results may be available upon reasonable request.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jan 2027, 1 month later.

Of 148 non-industry observational studies under Hypotension, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 25. This study's planned 1 month is below that.

Counting every sponsor, half of 153 studies reached it within 11 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 15, 2026
First posted
Nov 19, 2026
StartEst.
Nov 15, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Dec 30, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07949825
Responsible party
Sponsor
First posted
Nov 19, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Tianlun Zhu, MD
Contact
ztl0217@zju.edu.cn
+86 18767969777
TianLun Zhu
principal investigator · The Fourth Affiliated Hospital, Zhejiang University School of Medicine

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion